
==== Front
BMC Pulm Med
BMC Pulm Med
BMC Pulmonary Medicine
1471-2466
BioMed Central London

3223
10.1186/s12890-024-03223-2
Research
Nontuberculous mycobacterial pulmonary disease presenting as bronchiolitis pattern on CT without cavity or bronchiectasis
Yoon Sung Hyun 1
Kim Hyung-Jun 23
Kim Jihang 1
Kim Junghoon 1
Lee Jae Ho jhlee7@snubh.org

23
1 https://ror.org/00cb3km46 grid.412480.b 0000 0004 0647 3378 Department of Radiology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
2 https://ror.org/00cb3km46 grid.412480.b 0000 0004 0647 3378 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
3 https://ror.org/04h9pn542 grid.31501.36 0000 0004 0470 5905 Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
2 9 2024
2 9 2024
2024
24 43217 1 2024
14 8 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Background

This study aimed to investigate the radiological changes in patients with nontuberculous mycobacterial pulmonary disease (NTM-PD) having bronchiolitis patterns on computed tomography (CT).

Methods

We retrospectively reviewed the final diagnosis and radiologic changes of patients suspected of having NTM-PD without cavity or bronchiectasis on CT image, between January 1, 2005 and March 31, 2021. NTM-PD was diagnosed based on the American Thoracic Society and Infectious Diseases Society of America criteria. The initial and final CT findings (bronchiectasis, cellular bronchiolitis, cavity formation, nodules, and consolidation) were compared between patients diagnosed with and without NTM-PD.

Results

This study included 96 patients and 515 CT images. The median CT follow-up duration was 1510.5 (interquartile range: 862.2–3005) days. NTM-PD was recognized in 43 patients. The clinical variables were not significantly different between patients with and without NTM-PD, except for underlying chronic airway disease (P < 0.001). Nodule and consolidation were more frequently observed on the initial CT scans of patients with NTM-PD compared with those without (P < 0.05). On the final follow-up CT scan, bronchiectasis (P < 0.001), cavity (P < 0.05), nodule (P < 0.05), and consolidation (P < 0.05) were more frequently observed in patients with NTM-PD. Among the 43 patients with NTM-PD, 30 showed a radiological progression on CT, with bronchiectasis (n = 22) being the most common finding. The incidence of bronchiectasis increased over time.

Conclusion

The bronchiolitis pattern on CT images of patients with NTM-PD showed frequent radiological progression during the follow-up period.

Keywords

Bronchiectasis
Bronchiolitis
Nontuberculous mycobacterial infection
Pulmonary infection
issue-copyright-statement© BioMed Central Ltd., part of Springer Nature 2024
==== Body
pmcBackground

Nontuberculous mycobacteria (NTM) are ubiquitous organisms found in water, soil, and soil dust [1]. NTM can cause infections of the lungs, sinuses, lymph nodes, and central nervous system in immunocompetent patients, and disseminated disease in patients with innate or acquired immunodeficiency [2, 3]. Among the many organs in which NTM can cause infection, the lungs are the most commonly affected [4]. Recent studies have shown that the incidence and prevalence of nontuberculous mycobacterial pulmonary disease (NTM-PD) are increasing globally [5–10].

Two radiological patterns of NTM-PD have been well recognized: fibrocavitary (FC) and nodular bronchiectatic (NB) [2, 11, 12]. The FC pattern features cavitary lesions mainly in the upper lobes and usually develops in older males with underlying lung diseases [11]. The NB pattern is characterized by bronchiectasis with multiple nodules and tree-in-bud opacities on computed tomography (CT) scans and occurs predominantly in postmenopausal nonsmoking female patients [11]. Consolidative and infiltrative patterns have also been reported [13, 14]; however, most previous studies have focused on FC and NB patterns.

The radiological appearance of NTM-PD is a combination of several findings, including cavity formation, bronchiectasis, consolidation, nodules varying in size, and bronchiolitis (centrilobular nodules with branching opacities) [15–18]. Among these findings, the bronchiolitis pattern is the most common, and was observed in 98% of patients with NTM-PD in a study [15]. In routine CT interpretation practice, it is difficult to specifically suspect NTM-PD when only a mild bronchiolitis pattern is observed without information on respiratory symptoms or a previous CT image. We theorized that a bronchiolitis pattern on CT may indicate an early finding of NTM-PD and may progress to a severe form of NTM-PD. This study aimed to investigate the clinical characteristics and radiological changes in patients with NTM-PD who exhibited a bronchiolitis pattern on CT.

Methods

Study population

We retrospectively examined the electronic medical records of patients referred to the outpatient respiratory clinic of a tertiary hospital between January 1, 2005 and March 31, 2021. We followed a stepwise approach to include patients who were referred under suspicion of NTM-PD and whose CT findings showed bronchiolitis without bronchiectasis or cavity formation.

Among the patients referred to the respiratory clinic, we first searched for those whose CT reports had keywords describing bronchiolitis (e.g., bronchiolitis, centrilobular nodule, branching opacity, tree-in-bud, and micronodule) and mentioned NTM infection as a differential diagnosis. Patients with chest CT reports mentioning a cavity or bronchiectasis, and those diagnosed with diffuse panbronchiolitis, pulmonary tuberculosis, tuberculous pleurisy, or sarcoidosis were excluded. Patients with a CT follow-up of < 1 year were excluded. Immunocompromised patients were excluded because pulmonary infections commonly occur in patients with overlapping radiological findings. Any patient suffering from a primary immunodeficiency or hematological malignancy, being treated with steroids or other immunosuppressive drugs for over 4 weeks, or having a history of solid organ or bone marrow transplantation were regarded as immunocompromised. Furthermore, we excluded patients whose CT findings were not likely to be NTM but other diseases with a similar CT appearance (e.g., diffuse panbronchiolitis, bronchopneumonia, or sarcoidosis) after closely reviewing the CT images and final clinical information. A board-certified chest radiologist reviewed all the CT images. The patients were categorized into those diagnosed and not diagnosed with NTM-PD. The diagnosis of NTM-PD was made based on the criteria proposed by the American Thoracic Society/Infectious Diseases Society of America [19]. This retrospective study was approved by the Institutional Review Board of Seoul National University Bundang Hospital (IRB No. B-2309-851-105), and the requirement for a written informed consent was waived.

Data collection and assessment

Baseline demographics at the time of the first visit were collected from the electronic medical records, including age, sex, body mass index, comorbidities, smoking history, and symptoms. Microbiological test results (NTM species and acid-fast bacilli [AFB] culture) and chest CT images obtained during the follow-up period were also collected.

AFB cultures from respiratory specimens were obtained using standard methods [20]. The microbiological criteria for NTM-PD were met when NTM was isolated from the sputum ≥ 2 times or from the bronchial washing after the first visit. NTM species and subspecies were identified by polymerase chain reaction restriction fragment length polymorphism analysis of the rpoB gene.

CT image review

Chest CT scans were conducted at our institution using multi-detector CTs, with a slice thickness of 3 mm at 2.5 mm intervals. CT images from external hospitals were considered acceptable if they were reconstructed with a slice thickness of < 3 mm and a slice interval smaller than the slice thickness, employing overlapping reconstruction.

The presence of five NTM-related CT findings on the initial and final CT scans was assessed [15]: bronchiectasis, cellular bronchiolitis, cavity formation, nodules, and consolidation. Bronchiectasis was defined as a condition in which the bronchial lumen diameter was greater than that of the adjacent pulmonary artery, without normal bronchial tapering. Cellular bronchiolitis was defined as the presence of centrilobular nodules (< 10 mm in diameter) and branching opacities (i.e., the tree-in-bud sign) observed on CT scans. Nodules were defined as solid oval or round lesions 10–30 mm in diameter. Consolidation was defined as a polygonal (not oval or round) homogeneous opacity that replaced the airspace and obscured the underlying pulmonary structures.

A previously published CT scoring system [15] was slightly modified and used to assess the radiological progression between the initial and final CT images (Table 1): bronchiectasis (maximum score, 6), cellular bronchiolitis (maximum score, 6), cavity (maximum score, 9), nodules (maximum score, 3), and consolidation (maximum score, 3). Since the aim of our study is to compare long-term changes in CT images, we removed the mucus plugging item from the bronchiectasis section of the original scoring system. This adjustment ensures that our scores more accurately reflect chronic irreversible changes rather than fluctuations in inflammation. Radiological progression was defined as present when the final CT score of any finding was greater than the initial CT score. A scoring system was not used to compare the CT images between the groups because the initial CT scores were generally expected to be small. The distribution of radiological abnormalities was analyzed based on the lobe and multilobe involvements and bilaterality. The lingular division of the left lung was considered the middle lobe.

During the image analysis, the original CT images were downloaded and reviewed without radiology report or clinical information, such as NTM diagnosis. The initial and final CT images of patients were independently assessed using a scoring system. After assessment by a board-certified radiologist (S.H.Y.), the results were compared with the original radiology reports written by board-certified radiologists. The time point of progression was evaluated in the patients with NTM-PD who exhibited radiologic progression.

Table 1 Computed tomography (CT) scoring system for the assessment of the extent of radiological abnormalities

CT finding	Score 0	Score 1	Score 2	Score 3	
Bronchiectasis (6 points)					
 Severity*	Absent	Mild	Moderate	Severe	
 Extent†	Absent	1–5	6–9	> 9	
Cellular bronchiolitis (6 points)					
 Severity‡	Absent	Mild	Moderate	Severe	
 Extent†	Absent	1–5	6–9	> 9	
Cavity (9 points)					
 Diameter	Absent	< 3	3–5	> 5	
 Wall thickness	Absent	< 1	1–5	> 5	
 Extent§	Absent	1–3	4–5	> 5	
Nodules (3 points)†	Absent	1–5	6–9	> 9	
Consolidation (3 points)†	Absent	< 3	3–5	> 5	
* Mild = bronchus diameter greater than adjacent vessel diameter; moderate = bronchus diameter 2–3 times the vessel diameter; severe = bronchus diameter > 3 times the vessel diameter

† Data represent the number of segments

‡ Mild = identifiable, peripheral lung, 1 cm from pleura; moderate = definite, involvement greater than 1–3 cm from pleura; severe = extensive, extending to central lung

§ Data represent the number of cavities

Statistical analysis

Data are presented as numbers (percentages) for categorical variables and medians (interquartile ranges) for continuous variables. Fisher’s exact test was used to compare the categorical variables. The Wilcoxon rank-sum test was used to compare the continuous variables. P-values < 0.05 were considered statistically significant. The statistical calculations were performed using the R 4.1.2 (R Foundation for Statistical Computing, Vienna, Austria) software.

Results

Patient characteristics

Among the 57,734 patients who visited the outpatient respiratory clinic and underwent a chest CT scan during the study period, 96 were suspected to have NTM-PD without bronchiectasis or cavity formation on CT. These patients underwent a total of 515 chest CT scans during the follow-up period.(Fig. 1).

Fig. 1 Flowchart of study population. NTM, nontuberculous mycobacteria; TB, tuberculosis; DPB, diffuse panbronchiolitis; CT, computed tomography

The median CT follow-up duration for 96 patients was 1510.5 days (interquartile range [IQR]: 862.2–3005 days). The median number of CT scans per patient was 4 (IQR: 3–6), and the median CT interval was 221 days (IQR: 61.5–419.5 days). All CT images were considered acceptable for the analysis. During the study period, 43 patients were subsequently diagnosed with NTM-PD and 53 were not, despite repetitive AFB culture tests (Table 2). Among the patients with NTM-PD, 26 patients were diagnosed by having ≥ 2 separate positive sputum culture results, and 17 were diagnosed by having ≥ 1 positive culture result from bronchial washings. None of the patients without NTM-PD met the microbiological criteria for NTM-PD. Among these, 7 patients had only one positive sputum culture result despite undergoing two or more sputum cultures. The remaining 46 patients consistently had negative sputum cultures. Patients with NTM-PD underwent fewer sputum or bronchial washing culture tests before the final diagnosis (P < 0.05), although the CT follow-up period was not significantly different. Other clinical variables were not significantly different between the two groups, except for underlying chronic airway diseases (chronic obstructive pulmonary disease (COPD) and asthma) (P < 0.001). There was 1 case of COPD and 1 case of asthma in the patients with NTM-PD, and 6 cases of COPD and 12 cases of asthma in the patients without NTM-PD. It took at least five negative AFB culture tests over 3 years until 90% of the NTM patients were diagnosed (Fig. 2).

Table 2 Clinical characteristics

	All (n = 96)	Patients diagnosed with NTM-PD (n = 43)	Patients not diagnosed with NTM-PD (n = 53)	P-value	
Age (years)*	63.1 (54.1–70.9)	62.6 (46.8–69.9)	64.5 (57–73.9)	0.112	
Sex				0.838	
Male	41 (42.7%)	17 (39.5%)	24 (45.3%)		
Female	55 (57.3%)	26 (60.5%)	29 (54.7%)		
BMI (kg/m2)*‡	21.9 (20.5–24.1)	21.6 (20.4–23.5)	22.2 (20.9–24.7)	0.509	
Smoking				0.431	
Nonsmoker	63 (65.6%)	30 (69.8%)	33 (62.3%)		
Ex-smoker	26 (27.1%)	11 (25.6%)	15 (28.3%)		
Current smoker	7 (7.3%)	2 (4.7%)	5 (9.4%)		
Chronic airway disease	20 (20.8%)	2 (4.7%)	18 (34.0%)	< 0.001	
History of TB	4 (4.2%)	2 (4.7%)	2 (3.8%)	1	
Symptom	65 (67.7%)	43 (100%)	22 (41.5%)	< 0.001	
CT follow-up (days)*	1510.5 (862.2–3005)	1593 (925–3244)	1446 (860–2650)	0.512	
Diagnostic delay (days)*	117 (15.5–1045.8)	113 (17.5–815)	212 (12–1312)	0.459	
AFB test

before diagnosis

					
Sputum culture†	2 (0–18)	1 (0–8)	3 (1–18)	< 0.001	
BW culture†	0 (0–3)	0 (0–2)	0 (0–3)	< 0.05	
Unless otherwise specified, the data are presented as numbers of patients with percentages in parentheses. Diagnostic delay was defined as the time (days) from the day of the initial CT scan to the final diagnosis (or the last AFB culture test in the patients not diagnosed with NTM-PD). AFB test before diagnosis was defined as the number of AFB tests conducted before the final diagnosis (or the total number of AFB tests for patients not diagnosed with NTM-PD)

NTM, nontuberculous mycobacteria; TB, tuberculosis; BMI, body mass index; AFB, acid-fast bacilli; BW, bronchial washing

* Data are presented as medians, with interquartile ranges in parentheses

† Data are represented as medians, with ranges in parentheses

‡ Values were missing (Patients diagnosed with NTM-PD:1, Patients not diagnosed with NTM-PD:2)

P-values were calculated using the Wilcoxon rank-sum test for age, BMI, CT follow-up period, diagnostic delay, sputum culture, and bronchoalveolar lavage (BAL) culture, and Fisher’s exact test for the other variables

Fig. 2 Cumulative diagnosis of NTM in the patients diagnosed with NTM-PD. (A) Cumulative diagnosis per the number of negative AFB tests before diagnosis. (B) Annual cumulative diagnosis of NTM-PD. NTM, nontuberculous mycobacteria; AFB, acid-fast bacilli

Comparison of the CT findings

There was no disparity between the scoring results of CT images and the original radiology reports. Regarding the initial CT findings, nodules and consolidations were present in different proportions, which were more frequently observed in patients with NTM-PD than in those without NTM-PD (P < 0.05) (Table 3). The presence of other findings was not significantly different between the two groups. The distribution of radiological abnormalities was not significantly different, except for the upper lobe involvement, which was more frequently observed in patients with NTM-PD.

The frequency of radiological abnormalities on the final CT image showed a significant difference between the groups in four of the five findings (Table 4). Bronchiectasis (P < 0.001), cavities (P < 0.05), nodules (P < 0.05), and consolidations (P < 0.05) were more frequently observed in patients with NTM-PD. The distribution of radiological abnormalities did not differ significantly between the two groups.

Table 3 Initial chest CT findings of NTM and non-NTM groups

	Patients diagnosed with NTM-PD
(n = 43)	Patients not diagnosed with NTM-PD
(n = 53)	P value	
Bronchiectasis	0 (0%)	0 (0%)	1	
Cavity	0 (0%)	0 (0%)	1	
Nodule	6 (14.0%)	1 (1.9%)	0.042	
Consolidation	13 (30.2%)	4 (7.5%)	0.006	
Bronchiolitis	43 (100%)	53 (100%)	1	
Involved lobes				
Bilaterality	30 (69.8%)	42 (79.2%)	0.826	
Multilobe	39 (90.7%)	46 (86.8%)	0.749	
Upper lobe	42 (97.7%)	43 (81.1%)	0.020	
Middle lobe*	32 (74.4%)	36 (67.9%)	0.508	
Lower lobe	29 (67.4%)	41 (77.4%)	0.357	
Data are numbers of patients, with percentages in parentheses

* The right middle lobe and lingular division of the left lung were regarded as middle lobes

P values were calculated by using the Fisher’s exact test

CT, computed tomography; NTM, nontuberculous mycobacteria

Table 4 Last chest CT findings of NTM and non-NTM groups

	Patients diagnosed with NTM-PD
(n = 43)	Patients not diagnosed with NTM-PD
(n = 53)	P value	
Bronchiectasis	22 (51.2%)	7 (13.2%)	< 0.001	
Cavity	6 (14.0%)	0 (0.0%)	0.007	
Nodule	11 (25.6%)	4 (7.5%)	0.023	
Consolidation	16 (37.2%)	7 (13.2%)	0.008	
Bronchiolitis	41 (95.3%)	49 (92.5%)	0.688	
Involved lobes				
Bilaterality	36 (83.7%)	40 (75.5%)	0.070	
Multilobe	36 (83.7%)	44 (83.0%)	1	
Upper lobe	41 (95.3%)	45 (84.9%)	0.177	
Middle lobe*	35 (81.4%)	35 (66.0%)	0.110	
Lower lobe	28 (65.1%)	40 (75.5%)	0.367	
Data are numbers of patients, with percentages in parentheses

* The right middle lobe and lingular division of the left lung were regarded as middle lobes

P values were calculated by using the Fisher’s exact test

CT, computed tomography; NTM, nontuberculous mycobacteria

The progression of each finding during the follow-up period was assessed using a scoring system and compared between the patients with and without NTM-PD (Fig. 3). Among the 43 patients with NTM-PD, the CT images of 30 patients (69.8%) showed a radiological progression. In comparison, 22 out of the 53 patients without NTM-PD (41.5%) exhibited radiological progression on their CT images. Additionally, of the 43 patients with NTM-PD, 11 (25.6%) received treatment, with 9 of these patients being in the radiologically progressive group. The mean increase in the total score for radiological abnormalities during the follow-up period was 2.05 in patients with NTM-PD and 0.08 in those without. Only the development of bronchiectasis and cavities differed significantly between the two groups (P < 0.01), with a higher frequency in patients with NTM-PD. Notably, the development of bronchiectasis was observed in 51.2% (22/43) of patients with NTM-PD and 73.3% (22/30) of those with radiological progression. The incidence of bronchiectasis increased over time in the NTM group (Fig. 4). The development and progression of bronchiectasis during the follow-up are shown in Figs. 5 and 6. Although the presence of nodules and consolidations was more common in patients with NTM-PD on both the initial and final CT scans, the progression of these two findings was not significantly different between patients with and without NTM-PD.

Fig. 3 Percentage of patients with aggravated radiological abnormality

Fig. 4 Cumulative incidence of bronchiectasis in patients with NTM-PD. NTM-PD, nontuberculous mycobacterial pulmonary disease

Fig. 5 Chest CT images of a female patient. (A) The initial CT image showed no bronchiectasis. Centrilobular and small nodules were observed in the anterior segment of the left upper lobe. (B) Bronchiectasis became evident after 5 years and centrilobular nodules were still observed but to a lesser extent. CT, computed tomography

Fig. 6 Chest CT images of a female patient. (A) The initial CT image showed no bronchiectasis. Centrilobular and small nodules were observed in periphery of the right middle lobe. (B) Bronchiectasis became evident after 10 years and centrilobular nodules were still observed. CT, computed tomography

NTM species

The identification of NTM species was performed in 42 of the 43 patients (Table 5). M. avium (n = 18) was the most frequently encountered species, followed by M. intracellulare (n = 12) and M. abscessus (n = 7). The other three patients were infected with M. avium complex (n = 1), M. fortuitum (n = 1), and an unidentified NTM (n = 1). The radiological progression was observed in more than half of the patients with M. avium, M. intracellulare, and M. abscessus infections. Nearly half of the patients with M. avium, M. intracellulare, and M. abscessus infections developed bronchiectasis during the follow-up.

Table 5 Isolated NTM species

	n	Radiologic Progression	Bronchiectasis	
Mycobacterium avium	18	10 (55.6%)	8 (44.4%)	
Mycobacterium intracellulare	12	9 (75%)	7 (58.3%)	
Mycobacterium abscessus	7	5 (71.4%)	3 (42.9%)	
Mycobacterium avium complex (MAC) *	1	1 (100%)	0 (0%)	
Mycobacterium fortuitum	1	1 (100%)	0 (0%)	
Unidentified NTM	1	1 (100%)	1 (100%)	
Mixed infection†	2	2 (100%)	2 (100%)	
Total	42	29	22	
Unless otherwise specified, data are numbers of patients, with percentages in parentheses

* Species identification was not possible for Mycobacterium avium complex

NTM, nontuberculous mycobacteria

Discussion

In this study, 96 patients who presented with bronchiolitis on CT scans but without bronchiectasis or cavities were followed up for a median follow-up period of 1510.5 days. Among 43 patients who were confirmed to have NTM-PD, 30 exhibited a radiological progression, mostly due to bronchiectasis. The progression to bronchiectasis and cavities was significantly more common in patients with NTM-PD than in those without.

Although NTM-PD manifest in various forms on CT scans [18, 21], previous studies have primarily focused on two well-known patterns: FC and NB [2, 11, 12]. Consequently, other patterns have received relatively little attention [22]. Based on our clinical experience, we have observed a significant number of patients with NTM-PD who exhibit bronchiolitis without bronchiectasis or cavity on CT. However, only one study specifically investigated the bronchiolitis subtype of pulmonary NTM infections [22]. Additionally, there is a lack of research on the radiological changes that occur from the early to late stages of NTM-PD. Therefore, the early manifestations of NTM-PD have not been thoroughly investigated.

Our study demonstrated that among patients with NTM-PD having a bronchiolitis pattern, the radiological abnormalities progressed over time. Notably, bronchiectasis was the most frequent new finding in patients with NTM-PD with a radiological progression, suggesting that the bronchiolitis pattern may serve as an early indicator of NTM-PD. However, distinguishing between patients with and without NTM-PD using CT scans, when they present solely with bronchiolitis, remains challenging. The only discernible difference based on initial chest CT findings was the slightly higher prevalence of nodules and consolidations (14.0% vs. 1.9% and 30.2% vs. 7.5%, respectively; P < 0.05) in patients with NTM-PD. These findings may assist in identifying patients with suspected NTM-PD who require a meticulous observation with additional follow-up CT scans.

Although the correlation between bronchiectasis and NTM-PD is well-established, the exact cause remains uncertain. In a study involving 221 patients with non-NTM bronchiectasis, 31 were diagnosed with NTM-PD during a median observation period of 37 months [23]. Moreover, individuals with bronchiectasis are reportedly 50–75 times more likely to have NTM infections compared to those without [24]. In contrast, pulmonary NTM infections may lead to bronchiectasis. According to the U.S. Bronchiectasis Research Registry, approximately 60% of patients with bronchiectasis had a history of NTM-PD or NTM cultured from sputum samples, and patients with NTM were more likely to exhibit diffusely dilated airways [25]. Another study that focused on patients with bronchiectasis revealed that patients with NTM-PD had a higher number of pulmonary segments affected by bronchiectasis [26]. No study has yet directly shown bronchiectasis development in NTM-PD via serial CT scans. Our study closely reviewed the CT images of patients with NTM-PD who initially presented with bronchiolitis and observed the development of bronchiectasis. The incidence of bronchiectasis increased over time in patients with NTM-PD, strongly indicating pulmonary NTM infection as a direct cause of bronchiectasis.

Diagnosis and surveillance of patients with NTM-PD can be challenging due to nonspecific clinical signs and the lack of a pathognomonic test [11, 27]. If NTM-PD is highly suspected and the initial tests are nondiagnostic, additional sputum cultures should be obtained. However, repeated cultures often show negative results. In addition, no consensus has been reached regarding the number of additional cultures and the length of intervals between the cultures to exclude NTM-PD safely. Considering that it took a minimum of five AFB tests over 3 years to diagnose 90% of patients with NTM-PD (Fig. 2), we recommend considering at least five repetitive AFB culture tests within 3 years for patients exhibiting a bronchiolitis pattern and suspected NTM-PD.

This study had several limitations. First, as the study was conducted at a respiratory clinic in a single tertiary hospital, our results may not be generalizable to a broader population. Second, this study was retrospective and involved a relatively small sample size. We included patients based on CT reports indicating bronchiolitis and mentioning NTM. Some patients without explicit mentions of NTM in the initial CT report might have been excluded, though this is likely rare. As patients were referred to the respiratory clinic and NTM is prevalent in South Korea, diagnosing NTM is of significant interest to both clinicians and radiologists. Consequently, mentions of NTM often emerged in subsequent follow-up CT reports, and these cases were included in this study. Further research using larger cohorts and a prospective approach is necessary to validate and expand upon our observations. Third, the definitive diagnosis of patients without NTM-PD remains unclear. With repeated AFB testing and longer follow-up durations, it is possible that some individuals initially not diagnosed with NTM-PD may later be diagnosed with NTM-PD or other related conditions.

Conclusions

The CT images displaying bronchiolitis patterns in patients with NTM-PD exhibited frequent radiological progression during the follow-up period. The most common observation among patients with NTM-PD showing radiological progression was the development of bronchiectasis. These results strongly indicate that pulmonary NTM infection directly leads to bronchiectasis. NTM-PD manifesting as a bronchiolitis pattern on CT scans necessitates thorough follow-up, including additional CT scans.

Acknowledgements

Not applicable.

Author contributions

The authors meet criteria for authorship as recommended by the International Committee of Medical Journal Editors, were fully responsible for all content, and were involved at all stages of manuscript development. Study conception and design: J.H.L. and S.H.Y.; Data collection: J.H.L., S.H.Y., and Jihang K.; Data Interpretation: J.H.L., S.H.Y., H.J.K., and Junghoon K.; and manuscript writing: J.H.L., S.H.Y., H.J.K., Jihang K., and Junghoon. K. As a corresponding author, J.H.L. has full access to all of the data in this study and takes complete responsibility for the integrity of the data and the accuracy of the data analysis. All authors have read and approved the manuscript.

Funding

No funding source.

Data availability

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Declarations

Ethics approval and consent to participate

This study was conducted in accordance with the amended Declaration of Helsinki. This retrospective study was approved by the Institutional Review Board of Seoul National University Bundang Hospital (IRB No. B-2309-851-105), and the requirement for a written informed consent was waived.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Abbreviations

FC Fibrocavitary

NB Nodular bronchiectatic

NTM-PD Nontuberculous mycobacteria pulmonary disease

NTM Nontuberculous mycobacteria

CT Computed tomography

AFB Acid-fast bacilli

IQR Interquartile range

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Cowman S, van Ingen J, Griffith DE, Loebinger MR. Non-tuberculous mycobacterial pulmonary disease. Eur Respir J 2019, 54(1).
2. Haworth CS Banks J Capstick T Fisher AJ Gorsuch T Laurenson IF Leitch A Loebinger MR Milburn HJ Nightingale M British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) Thorax 2017 72 Suppl 2 ii1 64 10.1136/thoraxjnl-2017-210927 29054853
Haworth CS, Banks J, Capstick T, Fisher AJ, Gorsuch T, Laurenson IF, Leitch A, Loebinger MR, Milburn HJ, Nightingale M, et al. British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). Thorax. 2017;72(Suppl 2):ii1–64.29054853 10.1136/thoraxjnl-2017-210927
3. Henkle E Winthrop KL Nontuberculous mycobacteria infections in immunosuppressed hosts Clin Chest Med 2015 36 1 91 9 10.1016/j.ccm.2014.11.002 25676522
Henkle E, Winthrop KL. Nontuberculous mycobacteria infections in immunosuppressed hosts. Clin Chest Med. 2015;36(1):91–9.25676522 10.1016/j.ccm.2014.11.002
4. Tortoli E Clinical manifestations of nontuberculous mycobacteria infections Clin Microbiol Infect 2009 15 10 906 10 10.1111/j.1469-0691.2009.03014.x 19845702
Tortoli E. Clinical manifestations of nontuberculous mycobacteria infections. Clin Microbiol Infect. 2009;15(10):906–10.19845702 10.1111/j.1469-0691.2009.03014.x
5. Shah NM Davidson JA Anderson LF Lalor MK Kim J Thomas HL Lipman M Abubakar I Pulmonary Mycobacterium avium-intracellulare is the main driver of the rise in non-tuberculous mycobacteria incidence in England, Wales and Northern Ireland, 2007–2012 BMC Infect Dis 2016 16 195 10.1186/s12879-016-1521-3 27154015
Shah NM, Davidson JA, Anderson LF, Lalor MK, Kim J, Thomas HL, Lipman M, Abubakar I. Pulmonary Mycobacterium avium-intracellulare is the main driver of the rise in non-tuberculous mycobacteria incidence in England, Wales and Northern Ireland, 2007–2012. BMC Infect Dis. 2016;16:195.27154015 10.1186/s12879-016-1521-3
6. Ringshausen FC Wagner D de Roux A Diel R Hohmann D Hickstein L Welte T Rademacher J Prevalence of Nontuberculous Mycobacterial Pulmonary Disease, Germany, 2009–2014 Emerg Infect Dis 2016 22 6 1102 5 10.3201/eid2206.151642 27191473
Ringshausen FC, Wagner D, de Roux A, Diel R, Hohmann D, Hickstein L, Welte T, Rademacher J. Prevalence of Nontuberculous Mycobacterial Pulmonary Disease, Germany, 2009–2014. Emerg Infect Dis. 2016;22(6):1102–5.27191473 10.3201/eid2206.151642
7. Prevots DR, Loddenkemper R, Sotgiu G, Migliori GB. Nontuberculous mycobacterial pulmonary disease: an increasing burden with substantial costs. Eur Respir J 2017, 49(4).
8. Izumi K Morimoto K Hasegawa N Uchimura K Kawatsu L Ato M Mitarai S Epidemiology of adults and Children Treated for Nontuberculous Mycobacterial Pulmonary Disease in Japan Ann Am Thorac Soc 2019 16 3 341 7 30339468
Izumi K, Morimoto K, Hasegawa N, Uchimura K, Kawatsu L, Ato M, Mitarai S. Epidemiology of adults and Children Treated for Nontuberculous Mycobacterial Pulmonary Disease in Japan. Ann Am Thorac Soc. 2019;16(3):341–7.30339468
9. Stout JE Koh WJ Yew WW Update on pulmonary disease due to non-tuberculous mycobacteria Int J Infect Dis 2016 45 123 34 10.1016/j.ijid.2016.03.006 26976549
Stout JE, Koh WJ, Yew WW. Update on pulmonary disease due to non-tuberculous mycobacteria. Int J Infect Dis. 2016;45:123–34.26976549 10.1016/j.ijid.2016.03.006
10. Brode SK Marchand-Austin A Jamieson FB Marras TK Pulmonary versus nonpulmonary nontuberculous mycobacteria, Ontario, Canada Emerg Infect Dis 2017 23 11 1898 901 10.3201/eid2311.170959 29048292
Brode SK, Marchand-Austin A, Jamieson FB, Marras TK. Pulmonary versus nonpulmonary nontuberculous mycobacteria, Ontario, Canada. Emerg Infect Dis. 2017;23(11):1898–901.29048292 10.3201/eid2311.170959
11. Griffith DE Aksamit T Brown-Elliott BA Catanzaro A Daley C Gordin F Holland SM Horsburgh R Huitt G Iademarco MF An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases Am J Respir Crit Care Med 2007 175 4 367 416 10.1164/rccm.200604-571ST 17277290
Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416.17277290 10.1164/rccm.200604-571ST
12. Ryu YJ Koh WJ Daley CL Diagnosis and treatment of Nontuberculous Mycobacterial Lung Disease: clinicians’ perspectives Tuberc Respir Dis (Seoul) 2016 79 2 74 84 10.4046/trd.2016.79.2.74 27066084
Ryu YJ, Koh WJ, Daley CL. Diagnosis and treatment of Nontuberculous Mycobacterial Lung Disease: clinicians’ perspectives. Tuberc Respir Dis (Seoul). 2016;79(2):74–84.27066084 10.4046/trd.2016.79.2.74
13. Gommans EP Even P Linssen CF van Dessel H van Haren E de Vries GJ Dingemans AM Kotz D Rohde GG Risk factors for mortality in patients with pulmonary infections with non-tuberculous mycobacteria: a retrospective cohort study Respir Med 2015 109 1 137 45 10.1016/j.rmed.2014.10.013 25464905
Gommans EP, Even P, Linssen CF, van Dessel H, van Haren E, de Vries GJ, Dingemans AM, Kotz D, Rohde GG. Risk factors for mortality in patients with pulmonary infections with non-tuberculous mycobacteria: a retrospective cohort study. Respir Med. 2015;109(1):137–45.25464905 10.1016/j.rmed.2014.10.013
14. Shu CC Lee CH Hsu CL Wang JT Wang JY Yu CJ Lee LN Clinical characteristics and prognosis of nontuberculous mycobacterial lung disease with different radiographic patterns Lung 2011 189 6 467 74 10.1007/s00408-011-9321-4 21956280
Shu CC, Lee CH, Hsu CL, Wang JT, Wang JY, Yu CJ, Lee LN. Clinical characteristics and prognosis of nontuberculous mycobacterial lung disease with different radiographic patterns. Lung. 2011;189(6):467–74.21956280 10.1007/s00408-011-9321-4
15. Kim HS Lee KS Koh WJ Jeon K Lee EJ Kang H Ahn J Serial CT findings of Mycobacterium massiliense pulmonary disease compared with Mycobacterium abscessus disease after treatment with antibiotic therapy Radiology 2012 263 1 260 70 10.1148/radiol.12111374 22371609
Kim HS, Lee KS, Koh WJ, Jeon K, Lee EJ, Kang H, Ahn J. Serial CT findings of Mycobacterium massiliense pulmonary disease compared with Mycobacterium abscessus disease after treatment with antibiotic therapy. Radiology. 2012;263(1):260–70.22371609 10.1148/radiol.12111374
16. Kim SJ Yoon SH Choi SM Lee J Lee CH Han SK Yim JJ Characteristics associated with progression in patients with of nontuberculous mycobacterial lung disease: a prospective cohort study BMC Pulm Med 2017 17 1 5 10.1186/s12890-016-0349-3 28056937
Kim SJ, Yoon SH, Choi SM, Lee J, Lee CH, Han SK, Yim JJ. Characteristics associated with progression in patients with of nontuberculous mycobacterial lung disease: a prospective cohort study. BMC Pulm Med. 2017;17(1):5.28056937 10.1186/s12890-016-0349-3
17. Moon SM Jhun BW Baek SY Kim S Jeon K Ko RE Shin SH Lee H Kwon OJ Huh HJ Long-term natural history of non-cavitary nodular bronchiectatic nontuberculous mycobacterial pulmonary disease Respir Med 2019 151 1 7 10.1016/j.rmed.2019.03.014 31047103
Moon SM, Jhun BW, Baek SY, Kim S, Jeon K, Ko RE, Shin SH, Lee H, Kwon OJ, Huh HJ, et al. Long-term natural history of non-cavitary nodular bronchiectatic nontuberculous mycobacterial pulmonary disease. Respir Med. 2019;151:1–7.31047103 10.1016/j.rmed.2019.03.014
18. Erasmus JJ McAdams HP Farrell MA Patz EF Jr Pulmonary nontuberculous mycobacterial infection: radiologic manifestations Radiographics 1999 19 6 1487 505 10.1148/radiographics.19.6.g99no101487 10555671
Erasmus JJ, McAdams HP, Farrell MA, Patz EF Jr. Pulmonary nontuberculous mycobacterial infection: radiologic manifestations. Radiographics. 1999;19(6):1487–505.10555671 10.1148/radiographics.19.6.g99no101487
19. Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ Jr., Andrejak C, Böttger EC, Brozek J, Griffith DE, Guglielmetti L et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Eur Respir J 2020, 56(1).
20. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med. 2000;161(4 Pt 1):1376–95. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999.
21. Martinez S McAdams HP Batchu CS The many faces of pulmonary nontuberculous mycobacterial infection Am J Roentgenol 2007 189 1 177 86 10.2214/AJR.07.2074 17579169
Martinez S, McAdams HP, Batchu CS. The many faces of pulmonary nontuberculous mycobacterial infection. Am J Roentgenol. 2007;189(1):177–86.17579169 10.2214/AJR.07.2074
22. Lee JH, Park YE, Chong YP, Lee HJ, Shim TS, Jo K-W. Radiologic subtypes and treatment outcome of unclassifiable type Mycobacterium avium Complex Pulmonary Disease. J Korean Med Sci 2023, 38(3).
23. Kwak N Lee JH Kim HJ Kim SA Yim JJ New-onset nontuberculous mycobacterial pulmonary disease in bronchiectasis: tracking the clinical and radiographic changes BMC Pulm Med 2020 20 1 293 10.1186/s12890-020-01331-3 33172424
Kwak N, Lee JH, Kim HJ, Kim SA, Yim JJ. New-onset nontuberculous mycobacterial pulmonary disease in bronchiectasis: tracking the clinical and radiographic changes. BMC Pulm Med. 2020;20(1):293.33172424 10.1186/s12890-020-01331-3
24. Seitz AE Olivier KN Adjemian J Holland SM Prevots DR Trends in bronchiectasis among medicare beneficiaries in the United States, 2000 to 2007 Chest 2012 142 2 432 9 10.1378/chest.11-2209 22302301
Seitz AE, Olivier KN, Adjemian J, Holland SM, Prevots DR. Trends in bronchiectasis among medicare beneficiaries in the United States, 2000 to 2007. Chest. 2012;142(2):432–9.22302301 10.1378/chest.11-2209
25. Aksamit TR O’Donnell AE Barker A Olivier KN Winthrop KL Daniels MLA Johnson M Eden E Griffith D Knowles M Adult patients with bronchiectasis: a First look at the US Bronchiectasis Research Registry Chest 2017 151 5 982 92 10.1016/j.chest.2016.10.055 27889361
Aksamit TR, O’Donnell AE, Barker A, Olivier KN, Winthrop KL, Daniels MLA, Johnson M, Eden E, Griffith D, Knowles M, et al. Adult patients with bronchiectasis: a First look at the US Bronchiectasis Research Registry. Chest. 2017;151(5):982–92.27889361 10.1016/j.chest.2016.10.055
26. Eisenberg I Yasin A Fuks L Stein N Saliba W Kramer MR Adir Y Shteinberg M Radiologic characteristics of non-tuberculous Mycobacteria Infection in patients with Bronchiectasis Lung 2020 198 4 715 22 10.1007/s00408-020-00371-0 32591896
Eisenberg I, Yasin A, Fuks L, Stein N, Saliba W, Kramer MR, Adir Y, Shteinberg M. Radiologic characteristics of non-tuberculous Mycobacteria Infection in patients with Bronchiectasis. Lung. 2020;198(4):715–22.32591896 10.1007/s00408-020-00371-0
27. Pennington KM Vu A Challener D Rivera CG Shweta FNU Zeuli JD Temesgen Z Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease J Clin Tuberc Other Mycobact Dis 2021 24 100244 10.1016/j.jctube.2021.100244 34036184
Pennington KM, Vu A, Challener D, Rivera CG, Shweta FNU, Zeuli JD, Temesgen Z. Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease. J Clin Tuberc Other Mycobact Dis. 2021;24:100244.34036184 10.1016/j.jctube.2021.100244
